Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim

Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças, Bernardo Marques da Silva, Edgar Avito Fernandes de Almeida

A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study Sheila Bermejo, Ester González, Katia López-Revuelta, Meritxell Ibernon, Diana López, Adoración Martín-Gómez, Rosa Garcia-Osuna, Tania Linares, Montserrat Díaz, Nàdia Martín, Xoana Barros, Helena Marco, Maruja Isabel Navarro, Noemí Esparza, Sandra Elias, Ana Coloma, Nicolás Roberto Robles, Irene Agraz, Esteban Poch, Lida Rodas, Víctor Lozano, Beatriz Fernández-Fernández, Eduardo Hernández, Maria Isabel Martínez, Ramona Ionela Stanescu, José Pelayo Moirón, Núria García-Fernández, Marian Goicoechea, Francesca Calero, Josep Bonet, Fernando Liaño, Julio Pascual, Manuel Praga, Xavier Fulladosa, María José Soler